Serving an Accelerated Market with mRNA Production
February 1, 2022
Tags:
Arranta Bio's Executive Chair and CEO Mark Bamforth discusses what the future holds for the company and what solidified the decision to expand into mRNA manufacturing, as well as what to expect next from this rapidly advancing platform.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
.svg)
